Lysophosphatidylinositol
Lysophosphatidylinositol (LPI) is a bioactive lipid that acts as a secondary messenger in the cell signaling process. It is a member of the lysophospholipid (LPL) family, which are lipids that have been modified by the addition of a phosphate group. LPI plays a crucial role in various biological processes, including cell proliferation, differentiation, and survival.
Structure[edit]
Lysophosphatidylinositol is composed of a glycerol backbone, a phosphate group, and a fatty acid chain. The glycerol backbone is linked to the phosphate group at the sn-3 position, and the fatty acid chain is attached to the glycerol backbone at the sn-1 position. This structure is what distinguishes LPI from other lysophospholipids, which have their fatty acid chains attached at the sn-2 position.
Function[edit]
Lysophosphatidylinositol functions as a signaling molecule in the body. It binds to the G protein-coupled receptor GPR55, which is involved in a variety of physiological processes, including pain perception, bone growth, and blood pressure regulation. LPI can also act as a ligand for other receptors, such as the cannabinoid receptor CB1 and CB2.
In addition to its role in cell signaling, LPI has been found to have other biological functions. For example, it can act as a mitogen, stimulating cell division and growth. It can also promote cell survival by inhibiting apoptosis, or programmed cell death.
Clinical significance[edit]
Abnormal levels of Lysophosphatidylinositol have been associated with various diseases, including cancer, neurodegenerative diseases, and cardiovascular diseases. For example, elevated levels of LPI have been found in the blood of patients with ovarian cancer, suggesting that it may play a role in the development or progression of this disease. Similarly, decreased levels of LPI have been observed in the brains of patients with Alzheimer's disease, suggesting a potential role in neurodegeneration.
See also[edit]
```
-
Lysophosphatidylinositol
Sponsored Health Resource

W8MD Weight Loss, Sleep & MedSpa
Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.
GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.
- Medical weight loss NYC
- Affordable GLP-1 injections NYC
- Budget GLP-1 weight loss shots Philadelphia
- New Jersey medical weight loss
- NYC medical weight loss blog
- Philadelphia weight loss blog
- Sleep medicine and sleep apnea services
- W8MD MedSpa and wellness
Book a W8MD appointment · View GLP-1 specials
Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian